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Introduction. Mixed states represent a frequent presentation of bipolar disorder, associated with higher resistance to psychophar-
macology. Limited evidence supports the use of ECT in these patients. We aim to report our experience on treating bipolar mixed
states with ECT. Methods. Retrospective data were collected from all bipolar patients submitted to acute ECT treatment, between
June 2006 and June 2011. Three groups were created in terms of affective polarity of the episode. CGI rating was used to establish
clinical remission and demographic and clinical variables were compared among groups. Long-term outcomewas assessed through
readmission measures, considering the use of continuation or maintenance ECT. Results. During the study time frame, a total of
50 ECT course treatments were performed on 41 bipolar patients. All affective episodes, except one mixed state, showed a positive
clinical response. Patientswithmixed state presentation tended to be younger and have an earlier first hospitalization than depressed
patients. No differences were found in terms of ECT sessions performed, length of hospital admission, referral to continuation ECT
treatment, number of readmissions, and time until next readmission. Conclusions. Our results support the effectiveness of ECT in
patients experiencing a mixed affective state.
1. Introduction
Bipolar mixed states were systematically described for the
first time by Kraepelin [1]. Since then, their high prevalence
has been repeatedly recognized, occurring in as many as
50% of all patients with affective bipolar disorders [2], but
they still remain poorly understood. Mixed states are known
to be associated with worse prognosis than depressive or
manic forms of bipolar disorder [3]. Comorbidities such
as substance abuse, traumatic brain injury, and other neu-
ropsychiatric and brain development impairments seem to
facilitate the emergence of mixed states [4]. Indeed, the risk
for developing mixed affective states appears to be nowadays
increased in part due to widespread use of antidepressants
[5] and substance abuse [6], and its occurrence might be
substantially underestimated by too restrictive classificatory
criteria. During the period that ranged from DSM-III to
DSM-IV-TR, in order to be diagnosed with a mixed state,
patients had to experience concurrent full depressive and
manic syndromes for more than one week, leaving aside
the majority of cases where subsyndromal mixed symptoms
were present [7–10]. The same still happens today under the
aegis of ICD-10 [11]. Some other unofficial classifications were
created that comprised broader criteria to diagnose mixed
state entities [12–14]. They generally require a minimum of
two or three symptoms of opposed polarity within a major
affective episode. Clinical validity and utility of entities such
as dysphoric mania or hypomania, depression with flight
of ideas, or excited depression have been substantially con-
firmed on empirical grounds [12, 14].
Lately, DSM-5 acknowledged and corrected this gap, intro-
ducing mixed features as a specifier of manic, hypomanic,
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and major depressive episodes in bipolar I or bipolar II
disorder or major depressive disorder [15]. This change of
practice, though late and controversial [16], may result in
a more prompt recognition of underlying bipolar diathesis
in depressed patients where no past history of manic/hypo-
manic episodes was identifiable, therefore allowing a more
suitable treatment, especially demanding a cautious use of
antidepressants.
Furthermore, the consequent increase in prevalence of
mixed states requires a better understanding of risk factors,
treatment, and prognosis of these patients. As a matter of
fact, they are usually extremely difficult to treat, many being
refractory to psychotropic drugs [17]. In comparison with
depressed patients, those afflicted with mixed states appear
to have longer and more severe episodes, higher frequency
of psychotic features, lower interepisodic remission, and
greater risk of suicide [18, 19]. Due to all these dissimilarities,
mixed states surely deserve to be analyzed per se, rather
than just being bundled within studies primarily focused
on depression or mania. In line with scientific evidence on
the effectiveness of Electroconvulsive Therapy (ECT) in the
treatment of both depressed and manic phases of bipolar
disorders, clinical experience also supports its use in mixed
states. Interestingly, in 1938, Cerletti and Bini departed from
animal studies to the first ever human trial of ECT in a patient
allegedly suffering from a mixed state episode with psychotic
symptoms [20]. There is, however, little information in the
scientific literature, supporting ECT to be equally efficacious
in these patients. Small et al. were among the first to sug-
gest ECT as a satisfactory approach in mixed states after
concluding that manic patients with concomitant depressive
symptoms showed larger improvements with ECT [21]. Since
then, five studies have been published on the efficacy of
ECT treatment in mixed state patients [22–26]; two of them
compared results to depressed patients [24, 25] and only one
to both depressed and manic patients [23]. Our study aims
to report our experience in using acute phase ECT (aECT)
for the purpose of relieving acute symptoms in patients with
mixed affective states that previously failed to respond to
pharmacotherapy, therefore adding scientific evidence to this
underexplored field of knowledge. Moreover, we analyse our
results with regard to the follow-up of these patients and
the outcomes of application of pharmacotherapy alone or in
conjunctionwith continuation (cECT) andmaintenanceECT
(mECT).
2. Methods
2.1. Patient Selection. We retrospectively collected clinical
data from all patients diagnosed with bipolar disorder treated
with aECT, in our unit (Department of Psychiatry of Hospital
Prof. Doutor Fernando Fonseca, EPE), between June 2006
and June 2011. Patients included were at least 18 years old and
treatment courses had to comprise a minimum of 2 sessions
of acute regularity and no interruption due to medical rea-
sons. Consideration for ECT treatment was clinically based,
and drug resistance remained the main criteria. All patients
included in the study failed to show consistent response
to psychopharmacology, although no formal assessment of
treatment resistance had been performed.
2.2. Data Collection. During the study period, some patients
presented more than one mood episode requiring aECT
treatment. As our main objective was to compare efficacy
of ECT on resolution of acute symptoms, an episode-based
approach was pursued. Bipolar affective episodes were split
up in three different groups according to its polarity and
evaluated in terms of clinical and treatment characteris-
tics (electrode placement, number of ECT sessions per
course, length of hospitalization, number of readmissions,
and time to readmission). For matters of clarity, a patient-
based comparison of clinical and demographic features was
performed. Patients were classified by the affective polarity
of the index episode. After resolution of acute symptoms
with index treatment, some episodeswere kept onmedication
alone whereas in others cECT (up to 6 months after aECT)
was added to prevent relapse. Among the latter, recurrence
prevention of new mood episodes after the end of cECT
was attained with medication alone or in combination with
mECT. In a secondary analysis of outcome, readmission rate
and time to readmission were compared between episodes
with either choice of treatment. Diagnoses of depressive and
manic episode were made when the patient met DSM-IV-
TR criteria [10], while mixed states were diagnosed according
to McElroy’s (mania/hypomania episode plus 3 or more
depressive symptoms) [12] and Akiskal’s criteria (major
depressive episode plus 2-3 manic/hypomanic symptoms)
[14]. Retrospective rating for severity of illness was made
using Clinical Global Impression (CGI), and a CGI-S score
equal to 3 (mildly ill) or less at the end of an aECT course was
adopted as a positive clinical response criterion.
2.3. ECT Treatment. Written informed consent for ECT was
obtained and treatments were administered twice a week. At
admission, all the patients were receiving psychotropic med-
ications, depending on physician’s choice, namely, antipsy-
chotics and mood stabilizers, though the latter as well as
benzodiazepines had been regularly interrupted the night
before each treatment, to minimize interference on the
seizure threshold or lithium neurotoxicity. Treatments were
performed with a SomaticsThymatron System IV Brief Pulse
device. Frequency (10–140Hz), pulse width (0.25–1.5ms),
duration (0.14–8.0 s), and current (0.9 A constant) measures
were automatically calculated, whereas energy (5–199.6 J) was
set according to dose-titration method using the recommen-
dations by the manufacturer [27]. Due to a change in the
internal protocol, ECT had been administered with either
bitemporal or bifrontal electrode placement, according to the
current practice at the time of treatment. Propofol and etomi-
date (doses dependent onweight and previous response)were
used as anaesthetic inducers, followed by the muscle relaxant
succinylcholine (0.5–1mg/kg). Patients were ventilated on
100%O
2
until resumption of spontaneous respiration. Length
of the generalized seizure elicited (≥15 seconds by motor
criteria) was used as a measure of adequacy of treatment.
Motor response was monitored using the cuff technique and
EEG was also recorded. In case of missed or inadequate
seizure, the patient was restimulated in increasing steps of
intensity up to a maximum of four stimulations in a row,
according to the same dose-titration schedule, after which
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Table 1: Demographic and clinical characteristics of the sample of patients (𝑛 = 41).
Bipolar depressed patients Bipolar manic patients Bipolar mixed patients
𝑝 value
(𝑛 = 22) (𝑛 = 4) (𝑛 = 15)
Females, 𝑛 (%) 17 (77.3%) 2 (50%) 11 (73.3%) 0.528a
Age, in years, on 31 July 2011, mean ± SD 57.9 ± 19.0 42.9 ± 13.1 45.0 ± 15.5 0.089b
Age, in years, at 1st admission due to
affective episode, mean ± SD 51.4 ± 19.4 32.8 ± 13.8 38.9 ± 16.0 0.061
c
Number of previous admissions, mean ± SD 1.8 ± 2.7 4.0 ± 1.4 2.7 ± 2.4 0.057d
aFreeman-Halton extension of the Fisher Exact Probability test; bKruskal Wallis test, 𝜒2 = 4.834, df = 2; cKruskal Wallis test, 𝜒2 = 5.605, df = 2; dKruskal
Wallis test, 𝜒2 = 5.747, df = 2.
titration was postponed to a following session [27]. Acute
ECT courses were terminated when the physician in charge
considered that the aimed therapeutic benefits were achieved
or whenever a sustainable appropriate response was followed
by a clinical plateau over two consecutive stimulations or in
case of unsatisfactory or absent symptomatic improvement
observed after, at least, four consecutive adequate seizures
with intensified stimuli. On follow-up, frequency of sessions
ranged from weekly to every 3 weeks in cECT and from
fortnightly to monthly in mECT.
2.4. Statistical Analysis. Because assumption of normality in
data could not be made, we had to rely on nonparametric
statistical tests. Comparisons between three groups were
performed using Chi-square analysis (or Freeman-Halton
extension of the Fisher Exact Probability test, when appro-
priate) for categorical variables and Kruskal-Wallis test for
continuous variables. Comparisons between two indepen-
dent groups were performed using Chi-square analysis (or
Fisher Exact Probability test) for categorical variables and
MannWhitney test for continuous variables.The significance
level for each test was established at 𝑝 < 0.05, 2-tailed. All
statistical analyses were performed using Statistical Package
for Social Sciences (SPSS-20.0, IBM Corporation, Armonk,
NY), except for the Freeman-Halton extension of the Fisher
Exact Probability test where a website for statistical compu-
tation was used (http://vassarstats.net/).
3. Results
Forty-four consecutive patients met inclusion criteria, but
3 were excluded due to incomplete information. Of the 41
patients that comprised our sample, 30 were female (73.2%)
and 11 were male (26.8%), while for ethnicity 30 were white
(73.2%) and 11 were black (26.8%). A total of 50 course
treatments were performed during the period of the study.
Interestingly, all the 9 patients included that had more than
one affective episode requiring ECT treatment had relapses
thatwere in the very same affective polarity. In particular, four
patients presented with two depressive consecutive episodes
and one patient with two mixed episodes demanding ECT
treatment. Two other patients had three relapses treated with
courses of ECT (one with three depressive episodes and the
other with three mixed episodes).
Overall, the mixed state group represented 36.6% (𝑛 =
15), the depressed group 53.7% (𝑛 = 22), and the manic
group 9.8% (𝑛 = 4) of the total population of patients. Table 1
presents the demographic and clinical features of these 3
subpopulations.
Due to the small size of themanic population, performing
comparisons was hindered. Therefore we repeated the com-
parisons, excluding the manic group. Because normality was
not observed in any of the variables for depressed and mixed
state population, nonparametric tests were used. Patients
diagnosed with mixed states tended to be younger than
depressed patients at the time of the study (𝑝 = 0.063) and at
first admission (𝑝 = 0.057), but no differences were observed
in the number of previous admissions (𝑝 = 0.157). Both
depressive and mixed state groups had a higher percentage
of female patients and no differences in gender distributions
were found (𝑝 = 1.000).
Considering the total number of 50 episodes that
demanded ECT treatment, psychotic symptoms were present
in 42.9% of depressive episodes and in 44.4% of mixed state
group. Two manic patients were psychotic while the other 2
were not (𝑝 = 0.999).
Due to a modification in the internal protocol that rules
our technical practice for applying ECT, a variable proportion
of patients within each group had one of two different elec-
trode placements. In the depressed group, 20 cases (71.4%)
had bitemporal electrodes, while 8 (28.6%) had bifrontal.
In the mixed group, in 8 (44.4%) of the cases electrodes
were bitemporally placed, and in 10 (55.6%) bifrontally. All
the four manic patients received bifrontal placement (𝑝 =
0.012). Differences between depressed andmixed group were
nonsignificant (𝑝 = 0.067).
Chart review of episodes’ descriptions at the moment of
referral to the ECT unit indicated moderate to severe mental
illness. All treatments but one in amixed state patient showed
positive clinical response, as documented on retrospective
rating of CGI equal or inferior to 3.
We also compared whether any relevant difference could
be found between groups in terms of number of ECT sessions
performed and length of hospital admission. These repre-
sent indirect measures of treatment efficacy and constitute
relevant dimensions of care concerning the cost-benefit of
this treatment. The average number of ECT sessions in
the mixed state group was slightly lower in mixed state
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Table 2: Clinical characteristics of the sample of episodes (𝑛 = 50).
Bipolar depressed episodes Bipolar manic episodes Bipolar mixed episodes
𝑝 value
(𝑛 = 28) (𝑛 = 4) (𝑛 = 18)
Number of ECT sessions, mean ± SD 5.9 ± 3.2 6.8 ± 3.3 5.1 ± 2.2 0.336e
Length of hospitalization during the
episode, in days, mean ± SD 39.2 ± 30.2 57.0 ± 22.3 44.7 ± 54.5 0.250
f
Continuation ECT, 𝑛 (%) 10 (35.7%) 3 (75.0%) 11 (61.1%) 0.174g
Readmission due to affective relapse, 𝑛 (%) 10 (35.7%) 0 (0%) 8 (44.4%) 0.179g
eKruskal-Wallis test, 𝜒2 = 2.180, df = 2; fKruskal-Wallis test, 𝜒2 = 2.770, df = 2; gFreeman-Halton extension of the Fisher Exact Probability.
Table 3: Readmission characteristics of episodes that were treated or not treated with cECT (𝑛 = 50).
Continuation ECT Yes No 𝑝 value
(𝑛 = 24) (𝑛 = 26)
Readmission due to affective relapse, 𝑛 (%) 8 (33.3%) 10 (38.5%) 0.920h
Time to readmission, in weeks, mean ± SD 73.6 ± 65.4 27.1 ± 30.5 0.248i
Total number of readmissions, 𝑛; mean ± SD 17; 0.71 ± 1.459 11; 0.65 ± 1.018 0.741i
hChi-square; iMann-Whitney 𝑈 test.
episodes than manic or depressive episodes, although not
reaching statistical significance. When considering the days
of hospitalization during the affective episode that moti-
vated ECT treatment, manic episodes were associated with
longer admissions than mixed states or depressive episodes
(Table 2). No difference arose from a direct comparison
between episodes of depression andmixed states (𝑝 = 0.955).
After the acute treatment, patients were put on psy-
chopharmacologic medication alone or augmented with
cECT. All patients in our sample were either on mood sta-
bilizer or antipsychotic medication, and in two thirds with
a combination of both. In the depressed group, 20 episodes
were put on mood stabilizers, 22 on antipsychotics, and 5 on
antidepressants (never in monotherapy). In what concerns
mood stabilizers, lamotrigine was the drug of choice in 12
depressive episodes while 5 were put on lithium and 3 on
sodium valproate; lamotrigine was associated thrice with
lithium and once with sodium valproate. Only one patient
with a depressed episode was put on long-acting antipsy-
chotic; four were on SSRI and one on SNRI. In themixed state
group, 11 episodes were medicated with mood stabilizers
(lithium and lamotrigine in 5 situations each, 3 of which
with both drugs combined; 4 with sodium valproate), 13 were
put on antipsychotic (of which 6 were on long-acting med-
ication), and no antidepressant was prescribed. Finally, in
the manic group, all 4 episodes were on combination of
mood stabilizer (3 with sodium valproate and 2 with lithium)
and antipsychotic (2 with long-acting drugs), and none on
antidepressant.
The choice for the combined approach of medica-
tion plus cECT was carried out in slightly more than one-
third of depressive episodes, while in the manic and mixed
state groups this decision was taken in more than two-thirds
of cases (Table 2). Direct comparison between depressive
and mixed state episodes revealed no statistical difference
(𝑝 = 0.132). Eight out of 10 (80.0%) of the depressive
episodes that started cECTwere kept onmaintenance regime,
while the proportion in mixed state group was of 7 out of
11 (63.6%). Only 1 manic episode (33.3%) kept taking ECT
after the 6months of continuation phase. No differences were
observed in a 3-group comparison analysis (𝑝 = 0.362) or
when excluding the manic group (𝑝 = 0.635).
The mean duration of follow-up was 136.4 ± 80.1 weeks
(range: 10.1–249.9 weeks), and no significant differences
were observed between depressed and mixed state groups
(depressed group = 149.0 ± SD 86.0 versus mixed group =
125.7 ± SD 76.4 weeks, 𝑝 = 0.344). Although the mixed state
group presented a higher percentage of episodes followed
by readmission due to affective relapse in comparison to
the depressive group, the absolute number of readmissions
that followed the index admission did not differ between
both groups (average number of readmissions: depressed
group = 0.6 ± SD 1.3 versus mixed group = 0.9 ± SD 1.3;
𝑝 = 0.353), neither did the average time to readmission
(mixed readmitted patients = 48.3± SD 62.0 versus depressed
readmitted patients = 47.3 ± SD 48.3 weeks; 𝑝 = 0.424).
Further analysis, irrespective of mood polarity, revealed
no differences in readmission rate in terms of selection
or not for cECT. One-third of mood episodes (8 in 24)
referred for cECT had to be readmitted during follow-
up; however, only 3 hospitalizations occurred while on this
treatment. Although no significant differences were observed
in terms of mean number of readmissions or time until next
hospitalization, readmission of episodes treated with cECT
occurred later (on average), albeit a high variability of this
measure. Moreover, the elevated number of readmissions in
the c-ECT group indicates a highly severe sample of patients
(Table 3). Among the group of episodes treated with cECT,
16 proceeded to maintenance modality (depressed group =
8, manic group = 1, mixed state group = 7), while 8 did not.
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A total of 11 readmissions occurred under mECT (versus 1
readmitted patient in the no-mECT group) but 5 of those
relapses took place in the very same patient (depressed
group). The percentage of admissions that occurred within
a period of time coincidental with ECT treatment (on either
continuation or maintenance regime) was equal in depressed
and mixed state group (7 out of 17 readmissions, 41.2%).
4. Discussion
This paper is intended as a reflection about the practice of
our department in the treatment of patients with bipolar
disorder, especially in what concerns their referral to the
ECT unit. Moreover, our customary practice of referring
mixed state patients to be treated with ECT called for a
systematic analysis of these data, in order to add it to the little
evidence available about the efficacy of ECT in the treatment
of bipolar episodes with mixed features. Our results support
the validity of ECT as an effective treatment formixed bipolar
episodes, comparable to the effect on relapses in depressive
and manic polarities. All the patients included in the study,
except one in the mixed group, showed a positive response
to aECT course. The number of ECT treatments did not
differ as a function of patient diagnostic group; however,
we could even appreciate a trend towards shorter course
treatments in themixed group. In part due to the appreciation
of adequacy of ECT treatment on mixed state patients,
three quarters of the episodes with acute treatment remained
on maintenance ECT. However, half of the episodes were
followed by the need for readmission, although almost half of
these patients were in maintenance treatment. These results,
although higher inmixed episodes, did not significantly differ
from the depressed group. The massive response rate across
all polarities prevented the finding of predictors of response.
As far as we know, only a disappointing number of five
studies had been published on the efficacy of ECT treatment
in patients with bipolar mixed states [22–26]. Gruber et al.
reported a series of 7mixed state cases submitted to ECT, stat-
ing that remission criteria were achieved in all patients and
both depressive and manic symptoms significantly improved
over ECT trials [22]. Devanand et al. also showed overlapping
benefits of ECT treatments over the three polarities of bipolar
episodes (depressed, 𝑛 = 38; manic, 𝑛 = 5; mixed, 𝑛 = 10),
even if mixed patients required longer hospitalizations and
aECT courses [23]. A study by Ciapparelli et al. did not find
any difference between treatment-resistant bipolar patients
with depression (𝑛 = 23) and mixed manic episodes (𝑛 = 41)
in terms of number of aECT sessions needed, althoughmixed
manic patients had a higher proportion of responders at
endpoint (26% versus 56%) [24]. Medda et al. also compared
bipolar depressed (𝑛 = 46) and mixed state patients (𝑛 =
50) and observed a similar number of ECT sessions between
groups (7.4 ± SD 2.5 versus 7.4 ± SD 2.4) and a more balanced
response rate (67.4% versus 76.0%) [25].The same group pub-
lished another study, focusing only on mixed state patients
treated with ECT. Response was achieved in 72.1% of the
sample. Several clinical and technical variables failed to show
association with quality of response. Nonresponders (27.9%
of total sample) had longer duration of the current mixed
episode. Remitters (30.5%) had less frequent OCD lifetime
comorbidity and presented at baseline with higher depressive
symptoms but lower manic features than responders and
nonresponders [26]. All these mentioned studies used DSM-
IV or Research Domain Criteria to diagnose mixed state,
differing in terms of requirements to qualify for response.
Due to the strong community-based model in which
our department is set up, patients with bipolar disorder
are assertively followed up by a mental health team in the
community. Whenever patients present with an affective
relapse, they are primarily treated as outpatients up to the
moment that severity of illness or lack of social support
requires admission to the inpatient unit. ECT remains as a
therapeutic resource to both outpatients and inpatients and is
considered whenever psychopharmacologic failure has been
detected. However, aECT treatment is usually taken as first
therapeutic strategy for patients that have been successfully
treated by that approach in previous affective episodes. In
fact, 9 out of the 50 episodes of aECT treatments analysed
refer to patients that had been adequately treated before. In
these cases ECT was proposed as a first-line treatment and
the patient consented to it. Our analysis by episode had the
limitation of considering each episode as independent when
in fact that was not the case in almost one-fifth of them.
Repeating the analysis excluding all the acute treatments in
previously treated patients did not change, however, any of
the reported results.
The retrospective and naturalistic set-up of this study
includes some limitations that we are aware of. Measures
of global improvement were attributed by chart review and
concomitant medication interferes with our aim to isolate
ECT therapeutic effect on bipolarmood episodes. Our higher
than normal response rate can be partially explained by the
retrospective and quite broad concept of response (CGI-S ≤
3), but also with a loser criterion of treatment resistance that
was not subject to formal assessment; our study sample is
therefore likely to comprise drug-responsive patients, had
the pharmacological approach been pursued in a longer and
more aggressive fashion. Additionally, a change of practice
in electrode placement (from bitemporal to bifrontal) could
have introduced a confounding variable that we did not
control for. However, the literature suggests that the clinical
differences between either of these bilateral techniques seem
to bemodest, if any, andmay rest upon slightly faster response
in bitemporal position and probably less cognitive effects
in bifrontal position, which was the rational for changing
our protocol [28–30]. The fact that more mixed patients
had bifrontal electrodes is likely a reflex of our increasing
referral of these patients for ECT treatment, since this is the
current established protocol in our unit.This late recognition
of mixed episodes as privileged candidates for ECT could
have shortened the follow-up time reducing the chances
for relapse or readmission. Having said that, analysis of the
duration of time since discharge to follow-up endpoint (June
2011), although slightly longer in depressed episodes, did not
significantly differ from mixed state ones. Careful analyses
of patients’ records did not report any relevant adverse event
during ECT sessions, and this comes in accordance with the
notion of high safety and tolerability of the procedure in
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patients with bipolar disorder [31]. Unfortunately, cognitive
measures were not systematically assessed in our study. The
small sample size is another major limitation. It is interesting
to highlight the low number of manic patients referred for
treatment with ECT. Several reasons concur to this fact.
First of all, the broadly inclusive criteria for the diagnosis of
mixed patients, ranging from excited depression to dysphoric
mania, have as a consequence a decreasing number of patients
diagnosed with depressive ormanic episodes.Therefore, only
pure depression and mania remained with this diagnostic
category. Becausewe require previous informed consent from
the patient when referring to ECT, a significant amount of
manic patients would have refused to be submitted to ECT
due to their lack of insight and grandiose psychopathologic
experiences. Finally, a superior arsenal of pharmacologic
choices is available to patients withmania, which implies that
successful treatments could have prevented considering ECT
as an alternative.
Despite these limitations, our sample had the advantage
to consider a broader concept of mixed states, joining the
current diagnostic trend of considering depression andmania
only in their most pure presentations. As far as we know,
this is the third study approaching the efficacy of ECT in
mixed state patients compared to other polarities of illness
and although these other papers did not report their data on
follow-up length, this is most likely one with the longest. In
fact, very little is known about the impact of aECT on the
long-term outcome of bipolar patients. Medda et al. recently
published a prospective naturalistic study that followed 36
bipolar patients with a medication-resistant severe depres-
sion or mixed state index episode that responded to aECT
(mean duration = 55.3 ± SD 30.4 weeks). Of these, 13 had
a depressive relapse, 5 months on average after the end of
acute treatment; one patient had a mixed state relapse [32].
Concordantly, among our episodes that were not referred for
cECT, half of readmissions occurred in the 15 weeks following
termination of aECT, supporting preliminary evidence that
the benefits of this treatment in bipolar patients tend to vanish
within the first months after last treatment [32].
Furthermore, although cECT and mECT have been
suggested, very limited data has been published so far [33, 34].
It is expected that the ongoing PRIDE study from the CORE
Group might bring some additional new evidence [35]. Our
results add, therefore, to the available evidence that mixed
state episodes are, at least, as responsive to aECT as depressive
and manic phases, suggesting that this treatment is adequate
to bipolar illness, regardless of the form of affective relapse.
Becausemixed states are especially refractory to conventional
psychopharmacological approaches, ECT should be consid-
ered as a valid alternative in the treatment of these patients.
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